DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection
- PMID: 7884923
- PMCID: PMC188955
- DOI: 10.1128/JVI.69.4.2684-2688.1995
DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection
Abstract
DNA vaccination has been evaluated with the lymphocytic choriomeningitis virus (LCMV) model system. Plasmid DNA encoding the LCMV nucleoprotein, when injected intramuscularly, induces both antiviral antibodies and cytotoxic T lymphocytes. Injection of DNA encoding the nucleoprotein or the viral glycoprotein confers protection against normally lethal LCMV challenge in a major histocompatibility complex-dependent manner. The protection conferred is incomplete, but it is most probably mediated by the induced cytotoxic T lymphocytes.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources